| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/07/2009 | CA2704428A1 Fgf9-related methods for treating anxiety |
| 05/07/2009 | CA2704357A1 Improved nogo-a binding molecules and pharmaceutical use thereof |
| 05/07/2009 | CA2704124A1 Method for inhibiting angiogenesis or for treatment of cancer |
| 05/07/2009 | CA2704119A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
| 05/07/2009 | CA2704059A1 Antigen-antibody complexes as hiv-1 vaccines |
| 05/07/2009 | CA2704038A1 Combination therapy to treat persistent viral infections |
| 05/07/2009 | CA2703989A1 Ehrlichia canis diva (differentiate infection from vaccinated animals) |
| 05/07/2009 | CA2703911A1 Molecules and methods for modulating complement component |
| 05/07/2009 | CA2703838A1 Diagnostic and therapeutic methods and compositions for cardiovascular disease |
| 05/07/2009 | CA2703825A1 New antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs |
| 05/07/2009 | CA2703770A1 Uses of a glycoprotein vi (gpvi) inhibitor |
| 05/07/2009 | CA2703385A1 Fc variants with altered binding to fcrn |
| 05/07/2009 | CA2702697A1 Engineered pertactin variants for vaccine use |
| 05/07/2009 | CA2702534A1 A multicomponent or monocomponent vaccine to be used against chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure |
| 05/07/2009 | CA2699218A1 Mycoplasma bovis vaccine and methods of use thereof |
| 05/06/2009 | EP2055780A2 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 05/06/2009 | EP2055715A1 Anticomplement polypeptides of ixodes ricinus |
| 05/06/2009 | EP2055316A1 Lentivirus vector-based approaches for generating an immune response to HIV in humans |
| 05/06/2009 | EP2055313A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
| 05/06/2009 | EP2055312A1 Molecular antigen array presenting amyloid beta |
| 05/06/2009 | EP2055311A1 Method for production of live smallpox vaccine |
| 05/06/2009 | EP2054444A2 Antibodies to erbb2 |
| 05/06/2009 | EP2054443A2 Antibodies to an epitope of agr2, assays and hybridomas |
| 05/06/2009 | EP2054431A2 Conformers of bacterial adhesins |
| 05/06/2009 | EP2054428A2 Development of dengue virus vaccine components |
| 05/06/2009 | EP2054083A1 A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |
| 05/06/2009 | EP2054081A2 Jc virus vaccine |
| 05/06/2009 | EP2054080A2 Treatment and prevention of allergic airways diseases |
| 05/06/2009 | EP2054077A2 Polypeptide derivatives of parathyroid hormone (pth) |
| 05/06/2009 | EP2054075A1 Treatment of graft-versus-host disease |
| 05/06/2009 | EP2054044A1 Medicament for lct poisoning |
| 05/06/2009 | EP1628683B1 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 05/06/2009 | EP1556404B1 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 05/06/2009 | EP1539785B1 Gene regulation in transgenic animals using a transposon-based vector |
| 05/06/2009 | EP1537206B1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1410022B1 Detection and treatment of prostate cancer |
| 05/06/2009 | EP1379671B1 Methods to culture circovirus |
| 05/06/2009 | EP1274851B1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 05/06/2009 | EP1272193B1 Synergistic combination therapy for treating cancer |
| 05/06/2009 | CN101426906A A novel class of therapeutic protein based molecules |
| 05/06/2009 | CN101426904A Cancerous disease modifying antibodies 141205-05 |
| 05/06/2009 | CN101426815A Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| 05/06/2009 | CN101426536A Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 05/06/2009 | CN101426528A Methods of using antibodies against human IL-22 |
| 05/06/2009 | CN101426527A Protein formulations |
| 05/06/2009 | CN101426526A Solution phase biopanning method using engineered decoy proteins |
| 05/06/2009 | CN101426525A Chimeric vaccine antigens against classical swine fever virus |
| 05/06/2009 | CN101426524A Compositions and methods for mucosal vaccination |
| 05/06/2009 | CN101426523A B cell-based vaccine loaded with the ligand of natural killer T cell and antigen |
| 05/06/2009 | CN101426522A Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs |
| 05/06/2009 | CN101426521A EPHA2 BiTE molecules and uses thereof |
| 05/06/2009 | CN101426514A HCV vaccines |
| 05/06/2009 | CN101423833A Method for preparing inhibin genetic engineering regulation antigen |
| 05/06/2009 | CN101423832A CpG motif having immunological enhancement function to porcine nucleic acid vaccine |
| 05/06/2009 | CN101423823A Porcine reproductive and respiratory syndrome recombinant adenovirus rAd-GF35 |
| 05/06/2009 | CN101423822A Porcine reproductive and respiratory syndrome recombinant adenovirus rAd-HS35 |
| 05/06/2009 | CN101423821A High-pathogenicity porcine reproductive and respiratory syndrome virus variation strain and use thereof |
| 05/06/2009 | CN101423811A Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof |
| 05/06/2009 | CN101423553A Human monoclonal antibodies to dendritic cells |
| 05/06/2009 | CN101423551A Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded; and uses thereof |
| 05/06/2009 | CN101422620A Cryptosporidum parvum bivalent nucleic acid vaccine and preparation method thereof |
| 05/06/2009 | CN101422609A Use of lentinan as hepatic C virus nucleic acid vaccine immunologic adjavant |
| 05/06/2009 | CN101422608A Preparation method of PRRSV ORF5 gene nucleic acid vaccine containing CpG sequence |
| 05/06/2009 | CN101422607A Peste des petis ruminants recombined goat pox virus movable carrier vaccine |
| 05/06/2009 | CN101422606A Livestock Asia I type foot-and-mouth disease virus resistance genetic engineering polypeptide vaccine and preparation method thereof |
| 05/06/2009 | CN101422605A Immunoloregulation type DNA vaccine capable of preventing Eimeria necatrix |
| 05/06/2009 | CN101422604A Immunoloregulation type DNA vaccine capable of preventing Eimeria acervulina |
| 05/06/2009 | CN101422485A Preparation method of spleen byproducts for producing homology anti-serum blood and transfer factor from fox, raccoon dog, mink |
| 05/06/2009 | CN100484956C Compound from catarrh mollase bacterial |
| 05/06/2009 | CN100484572C Specific effervescent tablet against candida albicans IgY |
| 05/06/2009 | CN100484571C Application of semen momordicae extract containing triterpene saponin |
| 05/06/2009 | CN100484570C Gene vaccine against SARS virogene and its construction and use |
| 05/05/2009 | US7528245 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 05/05/2009 | US7528240 Method for producing human anti-thymocyte immunoglobulins |
| 05/05/2009 | US7528239 Receptor that binds trail |
| 05/05/2009 | US7528237 Binding to monoclonal antibodies; antitumor agents |
| 05/05/2009 | US7528236 Humanized anti-beta7 antagonists and uses therefor |
| 05/05/2009 | US7528225 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases |
| 05/05/2009 | US7528224 Human Leucocyte antigen-A2 binding peptide having an amino acid sequence from a signal peptide encoded by the MUC-1 gene; immune reaction against tumor cells further increased by the simultaneous use of cytotoxic T cells directed against both peptides presented by MHC-1 molecules. |
| 05/05/2009 | US7528223 Polypeptide encoded by an alternative reading frame of an influenza virus |
| 05/05/2009 | US7528109 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 05/05/2009 | US7527973 Monoclonal antibody or an antigen binding fragment that specifically binds amino acids of a West Nile virus E protein |
| 05/05/2009 | US7527972 Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation |
| 05/05/2009 | US7527969 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 05/05/2009 | US7527967 Recombinant baculovirus and virus-like particle |
| 05/05/2009 | US7527966 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 05/05/2009 | US7527960 Recombinant canarypox or fowlpox vector comprising a nucleic acid molecule encoding foot-and-mouth disease virus antigen |
| 05/05/2009 | US7527949 Polysaccharides of Helicobacter pylori |
| 05/05/2009 | US7527936 Modulators of angiogenesis |
| 05/05/2009 | US7527925 Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct |
| 05/05/2009 | US7527810 Oral immunology using plant product containing hepatitis surface antigen |
| 05/05/2009 | US7527802 For therapy against infections by pathogens such as, for example, enterotoxigenic Escherichia coli (ETEC) and/or for symptoms of diarrheal disease caused thereby |
| 05/05/2009 | US7527801 Norovirus and Sapovirus antigens |
| 05/05/2009 | US7527800 Influenza hemagglutinin and neuraminidase variants |
| 05/05/2009 | US7527798 Composition and method for preventing or treating a virus infection |
| 05/05/2009 | US7527797 Capsular polysaccharide of Vibrio cholerae O139 covalently bound with an adipic acid dihydrazide linker to a recombinant diphtheria toxin carrier protein eliciting serum vibriocidal antibodies; conjugated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), |
| 05/05/2009 | US7527796 Constructing recombinant gene encoding immunoglobulin fusion for use in diagnosis, prevention and treatment of equine viral disease; veterinary medicine |
| 05/05/2009 | US7527795 Peptide epitopes of apolipoprotein B |
| 05/05/2009 | US7527793 Immunogenic peptides |